Iodine Status and Characteristics of Papillary Thyroid Cancer
Not yet recruiting
- Conditions
- Papillary Thyroid Carcinoma
- Registration Number
- NCT06626581
- Lead Sponsor
- Shandong Provincial Hospital
- Brief Summary
The effect of iodine on papillary thyroid cancer has been controversial for many years. The investigators designed a cross-sectional study and aimed to explore the relationship between the serum and urine iodine levels and the clinical and molecular characteristics of papillary thyroid cancer.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 600
Inclusion Criteria
- Age range: 18~65 years old, gender not limited;
- Living in the residential area for at least 5 years;
- Patients diagnosed clinically with thyroid cancer and scheduled for thyroid surgery, with pathological diagnosis of papillary thyroid cancer;
- Complete clinical data: including general information, relevant laboratory tests, pathological reports, surgical reports, ultrasound reports, etc.
Exclusion Criteria
- Pathological diagnosis of other types of thyroid cancer;
- Diagnosed with other types of cancer;
- There are serious comorbidities of the heart, liver, and kidneys;
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum and urine iodine levels 1 year from enrollment TNM staging of papillary thyroid cancer 3 month from enrollment
- Secondary Outcome Measures
Name Time Method